Pacifica Partners Inc. Cidara Therapeutics, Inc. Transaction History

Pacifica Partners Inc.

  • $235 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 08, 2021
BUY
$2.06 - $3.01 $16,480 - $24,080
8,000 New
8,000 $21,000

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email